Vanflita tablets 26.5mg, containing Quizartinib hydrochloride, are manufactured by Daiichi Sankyo. This medication (YJ code: 4291060F2028, 26.5 mg 1 tablet) is a kinase inhibitor primarily used for treating certain types of acute myeloid leukemia (AML).
Vanflita tablets 26.5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →